MYCOSIS FUNGOIDES

This early-stage trial is testing the safety of a new gene therapy for adults with certain T-cell lymphomas that have returned or not responded to prior treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to target a protein (CCR4) foun…

This study is testing whether a light-based blood treatment called photopheresis can help control early-stage cutaneous T-cell lymphoma (CTCL), a type of skin cancer. Researchers want to see if using this treatment earlier in the disease course, rather than just for late stages, …

This study is testing whether very low doses of radiation can effectively control skin lesions caused by mycosis fungoides, a type of skin lymphoma. It aims to see if this approach can manage the disease while potentially causing fewer side effects than standard, higher-dose radi…

This study is testing an oral medication called golidocitnib for people with slow-growing T/NK-cell lymphomas that have come back or haven't responded to prior treatments. The goal is to see if this once-daily pill can effectively shrink tumors and control the disease. Researcher…

This study is testing whether a combination of a gentle, full-body radiation treatment and a targeted drug can help control mycosis fungoides, a type of skin lymphoma, in patients whose disease has come back or hasn't responded to other treatments. The trial will enroll about 30 …

This study is testing whether a gel called HyBryte, which is activated by a special light, can help treat early-stage cutaneous T-cell lymphoma (CTCL), a type of skin cancer. About 80 participants will apply the gel or a placebo to their skin patches twice a week for 18 weeks, fo…

This study is testing whether a lower dose of the cancer drug brentuximab vedotin can effectively treat certain types of skin lymphoma while potentially causing fewer side effects. It is enrolling adults with mycosis fungoides, Sezary syndrome, or lymphomatoid papulosis who need …

This early-phase study is testing a new treatment approach for patients with T-cell lymphoma that has returned or stopped responding to standard therapies. Researchers are combining a genetically modified virus designed to attack cancer cells with two immunotherapy drugs that hel…

This is an early-stage study testing a new intravenous drug called ST-001 for people with T-cell lymphoma that has come back or not responded to prior treatments. The main goals are to find the highest safe dose and understand how the drug works in the body. It is for adults whos…

This study is monitoring how safe and effective the drug Poteligeo (mogamulizumab) is for patients in Korea who are already using it to treat two rare types of skin lymphoma. It will follow about 15 adult patients who have tried at least one other treatment before. The goal is to…

This study aims to understand what happens to people long-term after being diagnosed with rare skin cancers called mycosis fungoides or lymphomatoid papulosis as children or teenagers. Researchers will contact 100 former patients (or their parents) to track their health status, t…

This study aims to collect blood, urine, and skin samples from adults with specific skin conditions like cutaneous T-cell lymphoma, eczema, or atopic dermatitis. The purpose is to build a collection of samples for researchers to study. By analyzing these samples, scientists hope …

This international study aims to create a better tool to predict survival for people with advanced mycosis fungoides and Sézary syndrome, two rare types of skin lymphoma. Researchers will follow 2,000 patients to collect detailed information about their disease and treatments. Th…